This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Children's Medical Center Corporation, The General Hospital Corporation. Active years: 2018.
Location History:
- Cambridge, MA (US) (2018)
- Boston, MA (US) (2018)
Company Filing History:
2 out of 1,072 
2 out of 3,068 
Years Active: 2018
Title: The Innovative Contributions of Serkan Cabi
Introduction
Serkan Cabi is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of obesity. With a total of 2 patents to his name, Cabi's work focuses on developing effective weight loss agents.
Latest Patents
Cabi's latest patents include compounds for the treatment of obesity and methods of use thereof. His research presents pentacyclic triterpene weight loss agents that are designed to be administered to pre-obese, obese, or morbidly obese patients. These pharmaceutical formulations contain a therapeutically effective amount of one or more weight loss agents, or pharmaceutically acceptable salts or prodrugs thereof, combined with one or more pharmaceutically acceptable excipients. The formulations aim to induce weight loss, reduce body fat, decrease food intake, improve glucose homeostasis, and prevent obesity. Additionally, the weight loss agents can be co-administered with leptin or a leptin analog to enhance their effectiveness.
Career Highlights
Throughout his career, Serkan Cabi has worked with reputable organizations such as Children's Medical Center Corporation and The General Hospital Corporation. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.
Collaborations
Cabi has collaborated with notable colleagues, including Umut Ozcan and Joseph Majzoub, to further advance his research and development efforts.
Conclusion
Serkan Cabi's innovative work in the field of obesity treatment showcases his dedication to improving health outcomes through pharmaceutical advancements. His contributions are paving the way for new therapeutic options in weight management.